These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34107326)

  • 21. The virological impacts of SARS-CoV-2 D614G mutation.
    Wang C; Zheng Y; Niu Z; Jiang X; Sun Q
    J Mol Cell Biol; 2021 Dec; 13(10):712-720. PubMed ID: 34289053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
    Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
    Elife; 2021 Feb; 10():. PubMed ID: 33570490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
    Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Genomic Sequencing Revealed N501Y and L452R Mutants of S/A Lineage in Tianjin Municipality, China.
    Li X; Gao X; Zou M; Zhuang Z; Tan Z; Zheng B; Yu A; Su X
    Virol Sin; 2021 Oct; 36(5):1228-1231. PubMed ID: 34379315
    [No Abstract]   [Full Text] [Related]  

  • 27. Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants.
    Landis JT; Moorad R; Pluta LJ; Caro-Vegas C; McNamara RP; Eason AB; Bailey A; Villamor FCS; Juarez A; Wong JP; Yang B; Broussard GS; Damania B; Dittmer DP
    mBio; 2023 Apr; 14(2):e0344822. PubMed ID: 36786605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
    Novazzi F; Baj A; Genoni A; Spezia PG; Colombo A; Cassani G; Zago C; Pasciuta R; Della Gasperina D; Ageno W; Severgnini P; Dentali F; Focosi D; Maggi F
    J Med Virol; 2021 Sep; 93(9):5648-5649. PubMed ID: 33969504
    [No Abstract]   [Full Text] [Related]  

  • 29. SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.
    Delgado JF; Vidal-Pla M; Moya MC; Espasa M; Casabella A; Seda M; Calvet J; Gratacós J; Serrano RM; Peña P
    J Immunol Res; 2022; 2022():8287087. PubMed ID: 35935586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The great escape? SARS-CoV-2 variants evading neutralizing responses.
    Prévost J; Finzi A
    Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.
    Mahmoudi Gomari M; Rostami N; Omidi-Ardali H; Arab SS
    J Biomol Struct Dyn; 2022 Aug; 40(12):5634-5642. PubMed ID: 33475020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
    Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
    PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy.
    Castelli M; Baj A; Criscuolo E; Ferrarese R; Diotti RA; Sampaolo M; Novazzi F; Dalla Gasperina D; Focosi D; Ferrari D; Locatelli M; Clementi M; Clementi N; Maggi F; Mancini N
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
    SeyedAlinaghi S; Mirzapour P; Dadras O; Pashaei Z; Karimi A; MohsseniPour M; Soleymanzadeh M; Barzegary A; Afsahi AM; Vahedi F; Shamsabadi A; Behnezhad F; Saeidi S; Mehraeen E; Shayesteh Jahanfar
    Eur J Med Res; 2021 Jun; 26(1):51. PubMed ID: 34103090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of the SARS-CoV-2 D614G Mutation Using VirSNiP SARS-CoV-2 Spike D614G Assay.
    Chen CC; Er TK
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
    Gunadi ; Wibawa H; Hakim MS; Marcellus ; Trisnawati I; Khair RE; Triasih R; Irene ; Afiahayati ; Iskandar K; Siswanto ; Anggorowati N; Daniwijaya EW; Supriyati E; Nugrahaningsih DAA; Budiono E; Retnowulan H; Puspadewi Y; Puspitawati I; Sianipar O; Afandy D; Simanjaya S; Widitjiarso W; Puspitarani DA; Fahri F; Riawan U; Fauzi AR; Kalim AS; Ananda NR; Setyati A; Setyowireni D; Laksanawati IS; Arguni E; Nuryastuti T; Wibawa T;
    BMC Med Genomics; 2021 Jun; 14(1):144. PubMed ID: 34074255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.
    Focosi D; Novazzi F; Genoni A; Dentali F; Gasperina DD; Baj A; Maggi F
    Emerg Infect Dis; 2021 Oct; 27(10):2728-2731. PubMed ID: 34314668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.